Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-29

Clinical Trial Update: The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1 [Phase 4]

View source ↗

Summary

Phase 4 trial update for dexamethasone ophthalmic insert timing around cataract surgery (in OR Day of surgery vs in-office Day 1 post-op).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone ophthalmic insert

Snippet

Sponsor: Joseph Kavanagh, MD | Conditions: Cataract | Phase 4 | Status: UNKNOWN